Correlation between reduced susceptibility to disinfectants and multidrug resistance among clinical isolates of Acinetobacter species

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 9, 2010, Pages 1975-1983

  Kawamura Sato, Kumiko ^a   Wachino, Jun Ichi ^b   Kondo, Takaaki ^a   Ito, Hideo ^a   Arakawa, Yoshichika ^b  

^a NAGOYA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Antimicrobial agent; Infection control; Nosocomial pathogen; Time dependent survey

Indexed keywords

ALKYLDIAMINOETHYLGLYCINE; AMIKACIN; ANTIINFECTIVE AGENT; BENZALKONIUM CHLORIDE; BENZETHONIUM CHLORIDE; CEFTAZIDIME; CHLORHEXIDINE GLUCONATE; CIPROFLOXACIN; DISINFECTANT AGENT; DYE; IMIPENEM;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER CALCOACETICUS; ACINETOBACTER JUNII; ACINETOBACTER LWOFFII; AGAR DILUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE TIME EFFECT RELATION; HOSPITAL; JAPANESE; MEASUREMENT; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; QUANTITATIVE ANALYSIS; SUSPENSION CELL CULTURE;

EID: 77955625139     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq227     Document Type: Article

References (33)

1. Bergogne-Bérézin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical and epidemiological features. Clin Microbiol Rev 1996; 9: 148-65.
2. Munoz-Price LS, Robert AW. Acinetobacter infection. N Engl J Med 2008; 358: 1271-81.
3. Paterson DL. The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species. Clin Infect Dis 2006; 43 Suppl 2: S43-8.
4. Pournaras S, Markogiannakis A, Ikonomidis A et al. Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit. J Antimicrob Chemother 2006; 57: 557-61.
5. de Vries J, Wackernagel W. Integration of foreign DNA during natural transformation of Acinetobacter sp. by homology-facilitated illegitimate recombination. Proc Natl Acad Sci USA 2002; 99: 2094-9.
6. Nielsen KM, van Weerelt MDM, Berg TN et al. Natural transformation and availability of transforming DNA to Acinetobacter calcoaceticus in soil microcosms. Appl Environ Microbiol 1997; 63: 1945-52.
7. Davis KA, Moran KA, McAllister CK et al. Multidrug-resistant Acinetobacter extremity infections in soldiers. Emerg Infect Dis 2005; 11: 1218-24.
8. Webster C, Towner KJ, Humphreys H. Survival of Acinetobacter on three clinically related inanimate surfaces. Infect Control Hosp Epidemiol 2000; 21: 246.
9. Kramer A, Schwebke I, Kampf G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis 2006; 6: 130.
10. Rutala WA. APIC guidelines for selection and use of disinfectants. Am J Infect Control 1996; 24: 313-42.
11. Makris AT, Morgan L, Gaber DJ et al. Effect of a comprehensive infection control program on the incidence of infections in long-term care facilities. Am J Infect Control 2000; 28: 3-7.
12. Russell AD. Bacterial resistance to disinfectants: present knowledge and future problems. J Hosp Infect 1999; 43 Suppl: S57-68.
13. Block C, Furman M. Association between intensity of chlorhexidine use and micro-organisms of reduced susceptibility in a hospital environment. J Hosp Infect 2002; 51: 201-6.
14. Martró E, Hernández A, Ariza J et al. Assessment of Acinetobacter baumannii susceptibility to antiseptics and disinfectants. J Hosp Infect 2003; 55: 39-46.
15. Wisplinghoff H, Schmitt R, Wöhrmann A et al. Resistance to disinfectants in epidemiologically defined clinical isolates of Acinetobacter baumannii. J Hosp Infect 2007; 66: 174-81.
16. Kawamura-Sato K, Wachino J, Kondo T et al. Reduction of disinfectant bactericidal activities in clinically isolated Acinetobacter species in the presence of organic material. J Antimicrob Chemother 2008; 61: 568-76.
17. Kõljalg S, Naaber P, Mikelssar M. Antibiotic resistance as an indicator of bacterial chlorhexidine susceptibility. J Hosp Infect 2002; 51: 106-13.
18. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing: Fourteenth Informational Supplement M100-S14. NCCLS, Wayne, PA, USA, 2004.
19. European Committee for Standardization. European Standard EN 1040: Chemical Disinfectants and Antiseptics. Basic Bactericidal Activity. Test Method and Requirements (Phase 1). Brussels, Belgium: CEN, 1997.
20. Dijkshoorm L, Nemec A, Seifert H. An increasing threat in the hospital: multidrug- resistant Acinetobacter baumannii. Nat Rev Microbiol 2007; 5: 939-51.
21. Nemec A, Dijkshoorm L, van der Reijden TJK. Long-term predominance of two pan-European clones among multi-resistant Acinetobacter baumannii strains in the Czech Republic. J Med Microbiol 2004; 53: 147-53.
22. Nemec A, Krízová L, Maixnerová M et al. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II. J Antimicrob Chemother 2008; 62: 484-9.
23. Nagano N, Nagano Y, Cordevant C et al. Nosocomial transmission of CTX-M-3 β-lactamase-producing Acinetobacter baumannii in a neurosurgery ward. J Clin Microbiol 2004; 42: 3978-84.
24. Doi Y, Wachino J, Yamane K et al. Spread of novel aminoglycoside resistance gene aac(6')-Iad among Acinetobacter clinical isolates in Japan. Antimicrob Agents Chemother 2004; 48: 2075-80.
25. Paul M, Weinberger M, Siegman-Igra Y et al. Acinetobacter baumannii: emergence and spread in Israel hospitals 1997-2002. J Hosp Infect 2005; 60: 256-60.
26. Nagai K, Murate T, Ohta S et al. Two different mechanisms are involved in the extremely high-level benzalkonium chloride resistance of a Pseudomonas fluorescence strain. Microbiol Immunol 2003; 47: 709-15.
27. Russell AD, Tattawasart U, Maillard J-Y et al. Possible link between bacterial resistance and use of antibiotics and biocides. Antimicrob Agents Chemother 1998; 42: 2151.
28. Kampf G, Jarosch R, Rüden H. Limited effectiveness of chlorhexidine based hand disinfectants against methicillin-resistant Staphylococcus aureus (MRSA). J Hosp Infect 1998; 38: 297-303.
29. Fraise AP. Susceptibility of antibiotic-resistant cocci to biocides. J Appl Microbiol Symp Suppl 2002; 92: 158S-62S.
30. Dance DAB, Pearson AD, Seal DV et al. A hospital outbreak caused by chlorhexidine and antibiotic-resistant Proteus mirabilis. J Hosp Infect 1987; 10: 10-6.
31. Russell AD. Do biocides select for antibiotic resistance? J Pharm Pharmacol 2000; 52: 227-33.
32. Turton JF, Gabriel SN, Valderrey C et al. Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii. Clin Microbiol Infect 2007; 13: 807-15.
33. Adams-Haduch JM, Paterson DL, Sidjabat HE et al. Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania. Antimicrob Agents Chemother 2008; 52: 3837-43.